Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase III Study of Corever for the Treatment of Hypertension

NCT02432937 is registered in ClinicalTrials.gov with TSH Biopharm Corporation Limited as lead sponsor.

NCT NCT02432937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02432937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase III Study of Corever for the Treatment of Hypertension
Lead sponsor
TSH Biopharm Corporation Limited
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2015
Completion date
August 31, 2016
Enrollment
134 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension